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Background. HIV is prevalent throughout South Africa, and diarrhoea is a common presentation to the emergency department (ED) 
among both HIV-infected and -uninfected individuals. 
Method. We audited the management of diarrhoea against standard guidelines in the ED of a regional hospital in KwaZulu-Natal. 
Patients presenting with diarrhoea as their chief complaint were eligible and data were collected prospectively. 
Results. A total of 72 patients were included: 58 (81%) of patients were HIV-positive with an average CD4+ count of 180 cells/ µl. A total 
of 34 stool samples were sent for standard microscopy and culture (M&C), among which 26 were positive (76%). Forty-three patients 
(60%) received antibiotics, 15 of whom had positive stool M&C. In all cases, the final diagnosis was listed as acute gastroenteritis 
without further specification, and antibiotic use according to guidelines appeared inconsistent. 
Conclusion. Based on this audit, we suggest that current guidelines are not clear concerning management of acute diarrhoea in HIV-
infected individuals, and that the lack of clear management strategies is likely to affect patient safety and increase antibiotic resistance. 
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HIV and related conditions are common causes 
of hospital presentations across South Africa 
(SA), and diarrhoea is a common presentation 
to the emergency department (ED) in high-
prevalence areas.[1,2] A differential diagnosis of 
any HIV-seropositive patient presenting with diarrhoea will thus 
need to consider a wider variety of infectious pathogens as well as 
non-infectious causes.[3,4] 
In SA, the Department of Health’s Essential Medicines 
List (EDL) has a list of guidelines concerning diarrhoea. 
It states that acute diarrhoea with blood or mucus in the 
stool is suggestive of acute inflammatory colitis and may 
have an infective cause. Stool culture is advised and a 
course of antibiotics is recommended. HIV/AIDS is not 
considered in the acute diarrhoea guidelines, only in the 
subsequent discussion of opportunistic infections that cause 
chronic diarrhoea, i.e. diarrhoea lasting >4 weeks.[5] With this 
background, we decided to audit the management of all types 
of diarrhoea against EDL guidelines in the ED of a provincial 
hospital in KwaZulu-Natal. 
Methods
All patients presenting to the ED with diarrhoea as their chief 
complaint were eligible for inclusion. Data were collected prospec-
tively, between February and April 2013, including demo -
graphic characteristics, HIV status, presenting symptoms, pre-
scription of antibiotics, blood results, final management, and stool 
microscopy and culture (M&C). We performed uni variate analysis 
of clinical predictors of positive stool M&C and admission, using 
Fisher’s exact test to examine statistical significance.
Results
A total of 72 patients were included (Table 1). We used estimated 
glomerular filtration rate (eGFR) and white cell count (WCC) 
as proxy indicators for severity. We considered an eGFR of 
<60 ml/ min/1.73 m2 to indicate renal impairment and a 
WCC of >11 × 109/l to indicate leucocytosis. CD4+ counts were 
available for 28/58 HIV-seropositive patients.
A total of 34 stool samples were sent for M&C. We considered 
the stool M&C positive, i.e. demonstrating an infection in the 
bowel, if any bacteria had grown (the laboratory tested for 
Salmonella spp, Shigella and Campylobacter) or there were 
white cells and/or yeasts present. No specimen grew bacteria, 
but 26 were positive for white cells and/or yeasts. 
Forty-three patients received antibiotics; Table 2 examines the 
use of antibiotics in relation to investigations and management. 
In all cases, a final diagnosis of acute gastroenteritis was made 
(no matter the duration), with no differentiation to suggest 
reason for choice or duration of antibiotic treatment. 
Discussion
The majority of the patients included in our audit presented with 
acute-onset diarrhoea, which had a median duration of only 3 
days. Upon presentation, the initial focus should be to resuscitate 
the patient with particular focus on fluid status, regardless of 
their HIV status. However, when considering the underlying 
condition, it is important to acknowledge the fact that most of 
the patients were severely immunocompromised.[3,4] 
A large proportion of patients were prescribed antibiotics, 
and this appears unrelated to severity of disease or possibility of 
being admitted. This prescribing practice, factoring in that 84% 
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were given only a single dose of antibiotics, puts the patient at risk of both 
undertreated infection and the development of a resistant organism. This 
is a very real possibility in a region with high HIV endemicity, as observed 
in other studies.[6,7] Furthermore, with HIV-positive patients being treated 
both prophylactically and more frequently with antimicrobial agents, the 
risks of resistance[8] and antimicrobial-related colitis caused by Clostridium 
difficile[2,9] are further increased. 
We found no correlation between positive stool microscopy and 
patient-reported symptoms of blood or mucus in the stool. There could 
be several reasons for this, and it would be worthwhile exploring this 
in more depth. In our audit, we requested stool M&C from a single 
specimen, which is a significant limitation, as multiple investigations are 
more likely to find a causative organism.[10] The feasibility of carrying out 
multiple investigations in the ED of a public hospital in a highly endemic 
area needs consideration. Algorithms for definitive diagnosis have been 
described, but require multiple investigations over multiple visits to a 
hospital with relatively advanced diagnostic facilities.[11]
Conclusion
This audit found that the population coming through the ED with 
diarrhoeal symptoms was predominantly HIV-positive with a low CD4+ 
count, and the signs and symptoms largely suggested acute episodes 
of infective diarrhoea leading to renal dysfunction and leucocytosis. 
Nevertheless, we found that the management was for the most part 
inconsistent and could put the patient at risk of both antibiotic 
resistance, or (as is the case for the use of ciprofloxacin) antibiotic-
related C. difficile colitis. Although the EDL guidelines offer guidance for 
antibiotic prescribing, clearer prescribing and management guidelines 
for acute diarrhoea in HIV-positive individuals, particularly in cases of 
AIDS, are needed. 
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Table 1. Demographics of audit population (N=72)
Admitted following presentation, n (%) 32 (44)
Age (years), mean (range) 39 (12 - 81)
Gender (female), n (%) 41 (57)
Duration of diarrhoea (days), median (range)  
Acute (lasting <28 days), n
Chronic (lasting ≥28 days), n
Duration unknown, n




HIV status (HIV-positive), n (%) 58 (81)
CD4+ count (cells/µl), median (range) 137 (6 - 480)
eGFR (ml/min/1.73 m2), mean (range)
<60, n
≥60, n
91 (9 - 282)
21
48
WCC (× 109/l), mean (range)
<11, n
≥11, n
9.25 (1.54 - 26.6)
53
15
eGFR = estimated glomerular filtration rate; WCC = white cell count.
Table 2. Use of antibiotics in all cases


















Leucocytosis and renal impairment (n=5)
Only leucocytosis (n=10)
Only renal impairment (n=16)
None of the above (n=37)















Antibiotics prescribed, as advised by the EDL guidelines, n (%) 25 (58) -
M&C = microscopy and culture; EDL = Essential Medicines List.
*Compared with no presence of leucocytosis or renal impairment.
